Mimic human complexity in a beat!
At BiomimX® we develop clinically relevant and fast responsive technology driven solutions tailored made to fit applications in Big Diseases.
Integrating 3D cell culture and mechanical stimulation, BiomimX® proposes the next generation of beating organs-on-chips, allowing to recapitulate human organs’ function and human diseased states with an unprecedented level of precision.
BiomimX® is a technology driven company projected towards the development of innovative and 3R compliant preclinical solutions that will revolutionize the standards for testing drug and medical devices.
DRUG DISCOVERY AND SAFETY
BiomimX® provides advanced human in vitro models to detect drug efficacy and adverse effects, representing a more clinically relevant alternative to existing models.
MEDICAL DEVICE ASSESSMENT
In line with the new EU Medical Device Regulation (MDR (EU)2017/745), BiomimX® offers advanced preclinical models to test medical device efficacy before undergoing clinical trials.
Future developments include envisioned precision medicine approaches, where candidate compounds and therapies are screened on disease- and, ultimately, patient-specific models.
Are you interested in applying for the prestigious Marie Curie Individual Fellowship #H20200 #MSCA-IF in the Society & Enterprise panel?
Applying with BiomimX® Srl as host institution will give you the opportunity to work with a dynamic and fast growing SME leader in the field of Organs on Chip!